• NHS TALKING THERAPIES

    Digital support across the whole NHS TT pathway

    Personalised, instantly accessible support to enhance care and optimise clinical outcomes.

  • NHS TALKING THERAPIES

    Digital support across the whole NHS TT pathway

    Personalised, instantly accessible support to enhance care and optimise clinical outcomes.

  • HOW WYSA SUPPORTS YOUR SERVICE

    NHS Talking Therapies services work better with Wysa

    Wysa works alongside your clinicians and your existing systems, extending what your team can offer at every stage of the pathway without replacing the human care at its centre.

  • HOW IT WORKS

    Here is how Wysa delivers support across the pathway

    Wysa is designed to fit around your existing clinical systems and workflows, not replace them.

  • IN PRACTICE

    Proven at scale

    185,000+

    clients supported via Wysa in NHS Talking Therapies services.

    91%

    of clients who start a self-referral complete and submit to the service.

    98%

    of clients feedback that Wysa’s support tools and AI self-help help them feel better.

    30 mins

    saved per client assessment, streamlining referrals and freeing up clinician time.

  • TESTIMONIALS

    What NHS TT services say

  • "Wysa allows patients to refer to our service easily and they can be offered some additional signposting at an earlier stage. The self-referral form means that patients can spend some time thinking about what they hope to get out of treatment before speaking with a clinician and can share their main difficulties with the assessor. This means that more time can be spent in the assessment exploring what is important to them and considering treatment options. The added bonus is that patients have access to the premium Wysa app, which can help them whilst they are waiting for treatment. We have had positive feedback about the app, with patients particularly liking the daily reminders to spend some time doing the exercises or simply taking some time to focus on their wellbeing"

    Kelly Colbeck

    Senior Service Lead (Urban), Dorset Steps2Wellbeing (NHS Talking Therapies)

  • CERTIFICATIONS

    Data privacy, security, and clinical safety are at the core of how Wysa is designed. Wysa was the first AI mental health app to meet NHS UK's DCB 0129 Standard of Clinical Safety. Wysa is a top ORCHA-approved app and has been awarded the Best in Privacy by Mozilla Foundations for two consecutive years - 2022 and 2023.

  • GET IN TOUCH

    See what this looks like for a service your size

    Book a 30-minute conversation with our NHS partnerships team. We will walk you through what Wysa does, how it fits your existing pathway, and what implementation typically involves.

  • Disclaimer: Wysa is not designed to assist with crises such as abuse, severe mental health conditions that may cause feelings of suicide, harm to self, and any other medical emergencies. Wysa cannot and will not offer medical or clinical advice. It can only suggest that users seek advanced and professional medical help. Please reach out to your country-specific suicide hotline in case of an emergency.

    You must be at least 18 years of age to use Wysa. If you are between 13 and 18 years of age, please read through the Terms of Service and Privacy Policy along with your parents or legal guardian to understand eligibility before use. Wysa is not designed to be used by children under 13.

  • Wysa is the top ORCHA approved app

    ORCHA recommends Wysa as the best NHS approved app for managing anxiety during COVID 19. With the impact of the pandemic on mental health, digital health resources emerged as a tool to self-manage. Wysa featured on a list of clinically approved apps to deal with health anxiety and feelings of isolation.

    First AI mental health app to meet Clinical Safety Standards

    We're proud to announce that Wysa now meets the NHS UK's DCB 0129 Standard of Clinical Safety.

     

    Prepared by the NHS Digital Clinical Safety team, DCB 0129 is designed to help manufacturers of Health IT software evidence the clinical safety of their products.

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More